TrialAutopsyBuilt by Jawad Momani (Pwnedl0l)

Autopsy report · NCT01314677

Fludeoxyglucose F 18 PET/CT Scans in Predicting Therapy Response in Patients With Stage IIIA Non-Small Cell Lung Cancer Undergoing Chemoradiation

Cause of deathStaffing, sites or logistics Automatic label, confidence 0.9, unverified. How labels are made.
“No subjects have been accrued to this trial. The PI will no longer be at COH and requests a study withdrawal/closure.”

The sponsor’s own words in the registry.

Life of this trial

201120122013Registered2011-03-11Planned start2011-04 (planned)Withdrawn (as of)2012-06-29

Vital statistics

Status
Withdrawn
Phase
Na
Sponsor
City of Hope Medical Center
Sponsor type
University, hospital or other
Conditions
Stage IIIA Non-small Cell Lung Cancer
Interventions
positron emission tomography/computed tomography (PET/CT); fludeoxyglucose F 18
Participants
0

Trials that died the same way

Look deeper

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.